FOI Request
- Disclosure ID
- FOI/03517
- Request Date
- January 17, 2020
- Subject
- Gastro Biologics
- Description
If you are unable to answer my questions with breakdown by specified conditions then please provide me with the numbers of patients treated in the last 3 months (October to December 2019 inclusive if possible) with the below drugs, regardless of disease/indication.
1). I have a Freedom of Information request for prescribing in Crohn’s Disease and Ulcerative Colitis.
Could you please confirm for the last three months (October to December 2019 inclusive if possible) the total biologic caseload for Crohn’s Disease, for each of the following treatments:
Adalimumab [Amgevita]
Adalimumab [Hulio]
Adalimumab [Humira]
Adalimumab [Hyrimoz]
Adalimumab [Imraldi]
Infliximab [Flixabi]
Infliximab [Inflectra]
Infliximab [Remicade]
Infliximab [Remsima]
Ustekinumab [Stelara]
Vedolizumab [Entyvio]
2). Also, could you please confirm for the last three months (October to December 2019 inclusive if possible) the total biologic caseload for Ulcerative Colitis, for each of the following treatments:
Adalimumab [Amgevita]
Adalimumab [Hulio]
Adalimumab [Humira]
Adalimumab [Hyrimoz]
Adalimumab [Imraldi]
Golimumab [Simponi]
Infliximab [Flixabi]
Infliximab [Inflectra]
Infliximab [Remicade]
Infliximab [Remsima]
Tofacitinib [Xeljanz]
Ustekinumab [Stelara]
Vedolizumab [Entyvio]
- Response
1). I can confirm for the last three months (October to December 2019 inclusive) the total biologic caseload for Crohn’s Disease, for each of the following treatments:
Adalimumab [Amgevita] = 19
Adalimumab [Hulio] = 0
Adalimumab [Humira] = 29
Adalimumab [Hyrimoz] = 0
Adalimumab [Imraldi] = 1
Infliximab [Flixabi] = 0
Infliximab [Inflectra] = 0
Infliximab [Remicade] = 1
Infliximab [Remsima] = 57
Ustekinumab [Stelara] = 12
Vedolizumab [Entyvio] = 11
2). I can confirm for the last three months (October to December 2019 inclusive) the total biologic caseload for Ulcerative Colitis, for each of the following treatments:
Adalimumab [Amgevita] =7
Adalimumab [Hulio] = 0
Adalimumab [Humira] = 8
Adalimumab [Hyrimoz] = 0
Adalimumab [Imraldi] = 0
Golimumab [Simponi] = 1
Infliximab [Flixabi] = 0
Infliximab [Inflectra] = 0
Infliximab [Remicade] = 0
Infliximab [Remsima] =30
Tofacitinib [Xeljanz] = 3
Ustekinumab [Stelara] = 0
Vedolizumab [Entyvio] = 14